Antiviral drugs for influenza for 2020-2021.

Med Lett Drugs Ther ; 62(1610): 169-172, 2020 11 02.

Article in English | MEDLINE | ID: covidwho-1017247

Subject(s)

Antiviral Agents/therapeutic use; Enzyme Inhibitors/therapeutic use; Influenza, Human/drug therapy; Influenza, Human/prevention & control; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; Drug Interactions; Drug Resistance, Viral; Enzyme Inhibitors/administration & dosage; Enzyme Inhibitors/adverse effects; Humans; Influenza, Human/complications; Neuraminidase/antagonists & inhibitors; Risk Factors; SARS-CoV-2; COVID-19 Drug Treatment

Keywords

FluMist; Rapivab; Relenza; Tamiflu; Xofluza; adverse effects; amantadine; antiviral drugs; baloxavir; coronavirus; dosage; drug interactions; efficacy; influenza; influenza vaccine; lactation; neuraminidase inhibitors; oseltamivir; peramivir; pregnancy; rimantadine; safety; zanamivir

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Enzyme Inhibitors / Influenza, Human Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Med Lett Drugs Ther Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links